Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Final Thoughts on Identifying and Managing Patients with T1D
Panelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
EP: 1.Living with Type 1 Diabetes
EP: 2.Screening Guidelines for Type 1 Diabetes
EP: 3.Stages and Symptoms of Type 1 Diabetes
EP: 4.Impact of Delayed Intervention in Stage 2 Type 1 Diabetes
EP: 5.Types of Antibody Screening Tests for Type 1 Diabetes
EP: 6.Overview of Teplizumab for Delaying Onset and Progression of Type 1 Diabetes
EP: 7.Patient Selection For Teplizumab and Infusion Process
Now Viewing
EP: 8.Final Thoughts on Identifying and Managing Patients with T1D
Related Videos
Related Content
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial
August 26th 2025Article
Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.
